1. Home
  2. PUBM vs SLDB Comparison

PUBM vs SLDB Comparison

Compare PUBM & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

HOLD

Current Price

$9.21

Market Cap

406.5M

Sector

Technology

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.81

Market Cap

464.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUBM
SLDB
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
406.5M
464.1M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
PUBM
SLDB
Price
$9.21
$5.81
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$18.45
$14.82
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
11-10-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$288,382,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.01
$2.41
52 Week High
$17.32
$7.37

Technical Indicators

Market Signals
Indicator
PUBM
SLDB
Relative Strength Index (RSI) 54.40 61.97
Support Level $8.91 $4.92
Resistance Level $9.24 $5.45
Average True Range (ATR) 0.35 0.37
MACD -0.00 0.16
Stochastic Oscillator 61.62 81.91

Price Performance

Historical Comparison
PUBM
SLDB

About PUBM PubMatic Inc.

PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: